Amiselimod, a novel sphingosine 1-phosphate receptor-1 modulator, has potent therapeutic efficacy for autoimmune diseases, with low bradycardia risk-Reference-Cited by-同舟云学术

Amiselimod, a novel sphingosine 1-phosphate receptor-1 modulator, has potent therapeutic efficacy for autoimmune diseases, with low bradycardia risk

Published:2016-11-17 Issue:1 Volume:174 Page:15-27
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:British Journal of Pharmacology

Author:

Sugahara Kunio¹,Maeda Yasuhiro¹,Shimano Kyoko¹,Mogami Akira¹,Kataoka Hirotoshi¹,Ogawa Kei²,Hikida Kumiko²,Kumagai Hiroshi²,Asayama Mahoko³,Yamamoto Toshinobu³,Harada Tomohiko⁴,Ni Pingping⁴,Inoue Shinsuke⁵,Kawaguchi Atsuhiro⁵

Affiliation:

1. Research Unit/Frontier Therapeutic Sciences, Sohyaku. Innovative Research Division; Mitsubishi Tanabe Pharma Corporation; Yokohama Japan

2. DMPK Research Laboratories, Sohyaku. Innovative Research Division; Mitsubishi Tanabe Pharma Corporation; Yokohama Japan

3. Safety Research Laboratories, Sohyaku. Innovative Research Division; Mitsubishi Tanabe Pharma Corporation; Saitama Japan

4. Mitsubishi Tanabe Pharma Europe, Dashwood House; London UK

5. Data Science Department, Sohyaku. Innovative Research Division; Mitsubishi Tanabe Pharma Corporation; Tokyo Japan

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.13641/fullpdf

Reference38 articles.

1. The Concise Guide to Pharmacology 2015/16: G protein-coupled receptors;Alexander;Br J Pharmacol,2015a

2. The Concise Guide to PHARMACOLOGY 2015/16: Voltage-gated ion channels;Alexander;Br J Pharmacol,2015b

3. Expression of the sphingosine 1-phosphate receptor, S1P1, on T-cells controls thymic emigration;Allende;J Biol Chem,2004

4. Second generation S1P pathway modulators: Research strategies and clinical developments;Bigaud;Biochim Biophys Acta,2014

5. Rpc1063, a potent, selective S1P1 receptor modulator, is active in a therapeutic IBD model and exhibits favorable PK/PD properties in healthy volunteers;Brooks;Gastroenterology,2013

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sphingosine‐1‐phosphate signalling in the heart: exploring emerging perspectives in cardiopathology;FEBS Letters;2024-07-04

2. Icanbelimod (CBP-307), a next-generation Sphingosine-1-phosphate receptor modulator, in healthy men: pharmacokinetics, pharmacodynamics, safety, and tolerability in a randomized trial in Australia;Frontiers in Immunology;2024-06-17

3. High-throughput screening of more than 30,000 compounds for anthelmintics against gastrointestinal nematode parasites;2024-05-18

4. 1-Phosphate receptor agonists: A promising therapeutic avenue for ischemia-reperfusion injury management;International Immunopharmacology;2024-04

5. Cardiovascular Evaluation of Etrasimod, a Selective Sphingosine 1‐phosphate Receptor Modulator, in Healthy Adults: Results of a Randomized, Thorough QT/QTc Study;Clinical Pharmacology in Drug Development;2024-03-05